Market Tracker

08/29 6:01pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

During the Trading Day
6.98 -0.05 / -0.71%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.98 +0.0008 / +0.01%
 
Volume: 22.0K

Today’s Trading

Previous close7.03
Today’s open7.03
Day’s range6.83 - 7.04
Volume942,882
Average volume (3 months)1,543,077
Market cap$735.3M
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+22.98%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...+1.10+4.15%
SAGESAGE Therapeutics In...-0.51-1.73%
HZNPHorizon Pharma Inc+0.14+1.38%
OREXOrexigen Therapeutic...-0.03-0.52%
Data as of 4:00pm ET, 08/29/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts